Latest Breaking News On - Digestive disease week - Page 1 : comparemela.com

Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at In

LAVAL, QC / ACCESSWIRE / June 14, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, recently presented at two global healthcare conferences. Bausch Health's gastroenterology (GI) business,.

Study: Colorectal Cancer Rates Rising Among Children, Teens

A catered low-fat, high-fiber diet 'new, hopeful option' to manage Crohn's disease

WASHINGTON — Patients with Crohn’s disease who ate a catered low-fat, high-fiber diet for 8 weeks experienced improvements in symptoms, inflammation and quality of life vs. those offered counseling alone, researchers reported. “We know that most patients with Crohn’s disease seek dietary counseling and ask their physicians about the foods they should consume,” Hajar

Entyvio effective in pediatric IBD, 'should be included in our treatment paradigm'

WASHINGTON — Entyvio is “safe and effective” for maintaining sustained steroid-free remission at 1 year in children with inflammatory bowel disease, more so in those with ulcerative colitis vs. Crohn’s disease, according to a researcher. “We know that children with inflammatory bowel disease, compared to adults, can have a more severe disease phenotype that is

Statin Use in Patients With IBD Tied to Lower PSC Risk

Statin use may contribute to a significant reduction in the risk for new primary sclerosing cholangitis among patients with inflammatory bowel disease.